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We previously reported on the association of Nef with a cellular serine kinase (E. T. Sawai et al., Proc. Natl. Acad. Sci.
USA 91, 1539–1543, 1994). In the present study, we further define the Nef sequence requirements for this kinase association
and investigate the effect of this kinase association on functions of HIV-1 Nef. We observe that, in addition to the membrane
targeting signal and the conserved arg–arg residues within the core region, mutations in the proline-rich domain of Nef
also affect its ability to associate with the serine kinase activity. The region encompassing the arg–arg residues of Nef is
shown to be important for Nef-mediated cell-surface CD4 down-modulation as well as enhancement of viral growth proper-
ties. This is similar to what has previously been observed for the membrane targeting site at the N-terminus of Nef. In
contrast, the proline-rich region of Nef is found to be involved in mediating efficient proviral DNA synthesis and the
enhanced virion-infectivity function, but is not necessary for CD4 down-modulation by Nef. Thus, it appears that serine
kinase association of Nef is necessary for efficient proviral DNA synthesis and for promotion of virion infectivity of Nef/
viruses, but is dispensable for down-regulation of the CD4 receptor by Nef. These findings define three functional domains
of Nef that are required for its interaction with the serine kinase activity and suggest that the cellular interaction events
via the myristoylation and arg–arg regions of Nef lie upstream of the interaction event via the proline-rich domain. q 1996
Academic Press, Inc.
INTRODUCTION al., 1993). In addition, Nef has been shown to down-
regulate the CD4 receptor molecule (Anderson et al.,
Nef was first identified as an open reading frame that
1993; Foster et al., 1994; Garcia and Miller, 1991; Guy et
overlaps with the 3* long terminal repeat in human immu-
al., 1990; Mariani and Skowronski, 1993) and promote
nodeficiency virus type 1 (HIV-1) (Allan et al., 1985). This viral growth (Chowers et al., 1994; de Rhonde et al., 1992;
gene is conserved in HIV-2 and in simian immunodefi- Kim et al., 1989; Miller et al., 1994; Spina et al., 1994;
ciency virus (SIV) (Myers et al., 1994). It codes for a small Terwilliger et al., 1986). These two effects of Nef function,
(27 kDa) myristoylated phosphoprotein found in the cyto- however, seem to be independent of each other (Chow-
plasm and inner plasma membrane of infected cells ers et al., 1995; Goldsmith et al., 1995; Miller et al., 1995).
(Franchini et al., 1986) and is expressed early in the viral Down-regulation of CD4 by Nef has been shown to be
replicative cycle (Feinberg et al., 1986; Robert-Guroff et mediated by an endocytotic mechanism that involves the
al., 1990). In the SIV model, Nef has been shown to be targeting of CD4 for lysosomal degradation (Aiken et al.,
required for the maintenance of high viral loads and pro- 1994; Rhee and Marsh, 1994; Schwartz et al., 1995),
gression to disease (Kestler et al., 1991). The mechanism whereas upregulation of viral growth appears to be medi-
whereby Nef is associated with pathogenesis, however, ated through an increase in the efficiency of reverse
is not well defined (for reviews, see Cullen, 1994; Ratner transcriptase in infected cells and to a resulting enhance-
and Niederman, 1995; Trono, 1995). ment of HIV-1 proviral DNA synthesis (Aiken and Trono,
Early biochemical studies indicated that Nef resem- 1995; Chowers et al., 1995; Schwartz et al., 1995). The
bles Ras, displaying both GTP-binding and GTPase activ- impaired infectivity of Nef-defective virions can be res-
ities (Guy et al., 1987, 1990). These findings, however, cued by expression of Nef protein in trans only in the
have not been confirmed by others (Backer et al., 1991; producer cells but not in the target cells (Miller et al.,
Harris et al., 1992; Kaminchik et al., 1991; Nebreda et al., 1995). Taken together, these findings suggest that Nef
1991). There have also been several reports showing influences viral infectivity at the stage of particle forma-
that Nef can exert effects on cell activation and prolifera- tion, perhaps indirectly by modifying another viral or cel-
tion (Baur et al., 1994; De and Marsh, 1994; Du et al., lular protein required in the early steps of the viral cell
1995, 1996; Greenway et al., 1994, 1995; Skowronski et cycle.
A comparison of the deduced amino acid sequences
of HIV-1, HIV-2, and SIV Nefs by Shugars et al. (1993)1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (212) 725-1126. reveal, in addition to the nearly invariant myristoylation
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signal at the N-terminus (residues 2–7), the presence of ing rabbits (Pocono Rabbit Farm & Laboratory) with re-
combinant Nef protein produced in yeast (supplied byfour highly conserved ‘‘Nef-defining’’ sequences (Blocks
A through D). Block A (residues 68 to 94; numbering Chiron Corp.).
according to HIV-1SF2 sequence; Luciw et al., 1984) en-
Generation of Nef expression vectors and proviralcompasses the acidic/charged region, the (Pxx)4 repeat,
vectorsand the potential PKC phosphorylation site. Block B in-
cludes residues 110 to 118, Block C spans positions 133 Plasmid 9B18, a pUC vector containing the full-length
to 152, and Block D extends from position 183 to 194. HIV-1SF2 infectious clone was used for generation of wild-
The conservation of these sequences suggests a role type virus. A 3.6-kb PstI fragment spanning the nef gene
for these regions in Nef function. Indeed, myristoylation was obtained from 9B18 and subcloned into the KSII(0)
of Nef has been shown to be important both for CD4 phagemid (Strategene). Single-stranded DNA generated
down-modulation by Nef and enhanced infectivity of from this phagemid was mutagenized with the Mutagene
Nef/ viruses (Aiken et al., 1994, 1995; Chowers et al., kit as specified by the supplier (Bio-Rad). Sequences of
1994), whereas the (Pxx)4 domain mediates up-regulation the oligonucleotides used to generate mutants are avail-
of virion infectivity, but has no effect on CD4 down-modu- able upon request. The presence of the mutations intro-
lation (Goldsmith et al., 1995; Saksela et al., 1995). duced in the nef gene was confirmed by sequencing. The
In an attempt to elucidate the pathway by which Nef wild-type and mutant nef genes were then subcloned into
exerts its effects, cellular proteins that complex with Nef the pRcCMV mammalian expression vector (Invitrogen)
were examined (Greenway et al., 1994; Harris and for transient expression and in vitro kinase analyses. A
Coates, 1993; Sawai et al., 1994). We previously reported 0.5-kb XhoI/BspEI fragment from a subset of the nef mutant
that Nef interacts with a cellular serine kinase that phos- sequences were also transferred into a pRcCMV/CD8/SF2
phorylates cellular proteins of 62 and 72 kDa which coim- Nef fusion plasmid (Baur et al., 1994) to generate mutant
munoprecipitate with Nef (Sawai et al., 1994). Further- CD8-Nef fusion expression vectors for CD4 down-modula-
more, we showed that the membrane targeting signal tion studies. This same subset of XhoI/BspEI mutant se-
and a central region of Nef (amino acids 45–127), in quences were transferred back to the full-length 9B18
particular the conserved arg–arg residues (amino acids genome. The clones were resequenced to confirm the
109/110), are required for Nef association with the serine presence of the mutant nef gene and then used in trans-
kinase activity (Sawai et al., 1995). The effects of this fection of 293 cells to generate mutant proviruses for infec-
kinase association on Nef functions, however, have not tivity studies. 9B18Xho(0) was prepared by digesting 9B18
been defined. In the present study, extensive genetic, at the unique XhoI restriction site, Klenow filling the ends
biochemical, and biological analyses have been con- and religating. This results in a Nef protein prematurely
ducted to identify additional amino acid residues within terminated at amino acid 38.
Nef that are required for mediating the observed serine
kinase activity and to determine the effect(s) of this ki- Generation of virus stocks
nase association on the various Nef functions.
Virus stocks were prepared as previously described
(Wiskerchen and Meusing, 1995a,b). Briefly, 293 cellsMATERIALS AND METHODS
(one 75-cm2 flask) at 40% confluency were transfected
Cells and antibodies with 15 mg DNA from the infectious proviral clones using
the CellPhect kit (Pharmacia Biotech Inc.). At 4 hr afterPeripheral blood mononuclear cells (PBMC) were pre-
addition of DNA, the cells were glycerol shocked,pared by Ficoll gradient centrifugation and propagated
washed with DMEM, and incubated in complete mediumin RPMI 1640 medium containing 10% heat-inactivated
for 40 hr at 377. Cell-free supernatants were harvested,(567, 30 min) AB human serum (Gibco/BRL). For prepara-
filtered through a 0.45-mm filter, and stored in aliquots attion of activated PBMC, cells were stimulated with phyto- 0707. Virus stocks were standardized by ELISA for p24hemagglutinin (3 mg/ml) for 2 days and then maintained
content (Coulter). p24 values for the viruses prepared byin RPMI 1640 growth medium containing 10% fetal calf
transfection of 293 cells did not vary by more than three-serum (FCS) and recombinant interleukin-2 (10 U/ml,
fold with the wild-type virus having the lowest value.generously provided by Hoffman–LaRoche Inc.). HeLa-
CD4-LTR-b-gal cells (MAGI cells, obtained through the
Metabolic labeling, immunoprecipitation, and in vitro
NIH AIDS Research and Reference Reagent Program
kinase assay
from Dr. M. Emerman) were propagated in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with For the in vitro kinase assay, 293 cells were trans-
fected with 10 mg pRcCMV-Nef wild type and mutant10% FCS, 0.2 mg/ml geneticin (G418; Gibco/BRL), and
0.1 mg/ml hygromycin B (Sigma). 293 cells were main- vectors and 0.5 mg of b-gal expression vector (pCH110,
Pharmacia) to monitor for transfection efficiency. Threetained in DMEM supplemented with 10% FCS. Polyclonal
antisera against HIV-1SF2 Nef was prepared by immuniz- days posttransfection, cells were harvested and assayed
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for b-gal activity and kinase activity as described (Sawai Transient CD4 down-regulation assay
et al., 1994). Half of the kinase reaction product was run
293 cells (7 1 105) were plated onto 60-mm plateson a 10% SDS–PAGE and autoradiographed.
containing 3 ml complete medium. Approximately 18 hrFor metabolic labeling and immunoprecipitation analy-
later, transient transfection was performed as describedses, parallel cultures were transfected as described
above with 3 mg pRcCMV-CD8-Nef expression con-above. Three days posttransfection, the cells were
structs, 1 mg human CD4 expression plasmid (pCD4, Len-washed in PBS and medium was replaced with DMEM
burg and Landau, 1993), and 1 mg pCH110. As controls,minus Met (ICN Biomedicals Inc.) for 1 hr at 377. The
a plasmid that expresses a native myristoylation-negativecells were then radiolabeled for 4 hr at 377 with 150 mCi
Nef protein (G2A) or a chimeric CD8-fusion protein with35S-met/ml in 2 ml DMEM minus Met medium. Cells were
Nef in the antisense orientation (CD8/antisense Nef)scraped and washed twice with PBS. A fraction (10%) of
were used together with pCD4 and pCH110. At 40 hrthe cells was assayed for b-gal activity with the use of
posttransfection, cells were harvested by scraping, por-the b-galactosidase enzyme assay system (Promega)
tions (40% each) of the CD8-Nef transfected cells wereand the remainder were lysed in 1 ml KEB buffer (Sawai
stained with a mixture of phycoerythrin (PE)-conjugatedet al., 1994). Transfection efficiencies, as determined by
anti-CD4 and fluorescein isothiocyanate (FITC)-conju-
b-gal activity, were comparable in the transfected cul-
gated anti-CD8, or with the corresponding PE- and FITC-tures used for in vitro kinase assay and radioimmunopre-
labeled iso-matched IgG mixtures as controls (Becton-cipitation. Immunoprecipitation was performed using 10
Dickenson). Another portion (10%) was used to prepare
ml polyclonal anti-Nef antiserum and 100 ml 1:3 dilution
cell lysates for b-gal assays to assure for comparableof protein A Sepharose (Pharmacia) as previously de-
efficiency of transfection. Immunostained samples werescribed (Sawai et al., 1994). Half of the product was ana-
analyzed for CD4 and CD8 expressions by two-color flowlyzed on a 12.5% SDS–PAGE and autoradiographed.
cytometry. Surface CD8 expression was used as a
marker for Nef expressing cells. Quadrants were drawn
Infectivity assay to delineate CD4-positive (upper left), CD8-positive
(lower right), and CD4/CD8-positive cells (upper right).For the MAGI assay, HeLa-CD4-LTR-b-gal (MAGI)
CD4 downregulation was determined by comparing thecells (0.4 1 105) were seeded in 12-mm wells and in-
percentage of CD4 expression on CD8-positive cellsfected 1 day later, in duplicate, with 200 ml inoculum
transfected with CD8/Nef and pCD4 expression plasmidscontaining 5 or 10 ng of p24 of the wild-type and mutant
to cells transfected with CD8/antisense Nef and pCD4.virus stocks and 20 mg DEAE/ml. Two hours after infec-
For the control G2A, the transfected cells were stainedtion at 377, 1 ml complete medium was added and the
with PE-conjugated anti-CD4 or iso-matched IgG, andcells were incubated for an additional 40 hr at 377. Cells
the percentage of CD4 expression was compared to cellswere fixed and stained as previously described (Kimpton
transfected with pCD4 and pCH110 alone.and Emerman, 1992) and blue cells were counted.
For infection of resting PBMC, 1.51 106 Ficoll gradient- PCR analysis of proviral DNA synthesis
purified PBMCs were infected, in duplicate, with 1.5 or 3.0
ng p24 of wild-type and mutant viruses overnight at 377 Viral stocks obtained from supernatants of transfected
293 cells were DNase-treated (20 mg/ml) for 30 min atin RPMI 1640 and 10% human AB serum. The infected
cells were then washed twice with Hanks to remove resid- 377 in the presence of 10 mM MgCl2 . p24 equivalent (250
ng) of each virus was used to infect MAGI cells (1.6 1ual virus and cultured in 2 ml RPMI 1640, 10% AB human
serum for 2 days at 377. PHA (2 mg/ml) was then added 106) for 1 hr at 377. The viral inoculum was then removed
(time zero), the infected cells washed twice with PBS,and the infected cells stimulated for 72 hr at 377. At the
end of the stimulation period, the cells were washed, re- trypsinized, washed once with PBS, and split into four
cultures. At the time of each harvest (0, 4, 8, and 24 hrsuspended in 2 ml RPMI 1640, 10% FCS and IL2. At various
time points postinfection, 1.5 ml of culture supernatant postinfection), 4 1 105 cells were harvested and lysed
in 100 ml lysis buffer (Von Schwedler et al., 1993). Unin-fluids were harvested for determination of p24 and the
cultures were refed with same amount of fresh medium. fected cells served as negative controls. PCR reactions
were performed on 25-ml lysates in 100-ml reaction mixesDay 0 represents the day when PHA was removed from
infected cultures. For infection of stimulated PBMC, 1.51 using primers LTR5 and LTR6 to detect early products
of reverse transcription and LTR5 and 5NC-2 primers to106 PHA-simulated PBMC were infected, in duplicate, with
0.5, 1.5, or 3.0 ng p24 of wild-type and mutant viruses detect viral DNA made after the second complete switch
of reverse transcription. Primers and reaction conditionsfor 1 hr at 377. The cells were then washed twice and
resuspended in RPMI 1640 medium containing FCS and have been previously described (Aiken and Trono, 1995).
The products were analyzed by electrophoresis in 1.2%IL2. At various times postinfection, culture supernatants
were harvested for determination of viral p24 as described agarose gels and Southern blotting. A 2.8-kb EcoRV frag-
ment of HIV-1SF2 (Luciw et al., 1984) encompasing nucleo-above. Day 0 represents the day of infection.
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TABLE 1 mote virion infectivity (Aiken et al., 1994, 1995; Chowers
et al., 1994). The functional effect(s) of the RR mutations,Amino Acid Requirements for Nef-Associated Kinase Activity
however, has not been reported (see below), but a CD8/
Kinase positive Nef fusion protein carrying the RR mutations is unable to
associate with the serine kinase activity (Sawai et al.,
S and T PxxP Charge residues Kinase negative 1995). All mutations introduced were confirmed by DNA
sequencing, and the mutated nef sequences were thenS14A P82A K7A, R8A G2A
placed into the mammalian expression vector pRcCMV.S38A P151A E18A, R19A P73A
T48A P151A, P154A R19A, R21A P76Aa The ability of the mutant proteins to associate with the
S49A R21A, R22A P79A serine kinase, as determined by phosphorylation of the
S50A E42A, K43A R109L, R110L 62 and 72-kDa proteins in in vitro kinase assays of Nef
T52A E66A, E67A R110L
immunoprecipitates, was examined by transient expres-T55A E67A, E68A
sion in 293 cells. Transfection efficiency, as monitoredT84A E68A, E69A
S107A E112A, D115A by the levels of b-galactosidase activity present in the
S173A E158A, E159A cotransfected cells, was not more than threefold different
S191A E159A for the various expression plasmids used. The results are
E162A, E164A
summarized in Table 1 and the expression and kinaseE178A, D179A
association of representative mutant Nef proteins are illus-H196A, H197A
R200A, E201A trated in Fig. 1.
H203A, E205A As shown in Table 1, amino acid substitutions of the
serine and threonine residues within Nef, including the
Note. 293 cells were transfected with wild-type and mutant Nef ex-
putative PKC phosphorylation site at position 84 (Shugarspression plasmids. 72 hours posttransfection, cell lysates were pre-
et al., 1993), have no effect on its ability to associate withpared, immunoprecipitated with anti-Nef antiserum and in vitro kinase
assays were performed on the immunoprecipitates. Phosphorylation the kinase activity. In contrast, alanine substitutions of
of the 62 and 72-kDa proteins is indicative of a kinase association. the proline residues at positions 73, 76, and 79 within
a Low levels of kinase association consistently detected with this the (Pxx)4 region (Block A) appear to abolish the abilitymutant Nef.
of the mutant proteins to associate with the kinase activ-
ity (Fig. 1A). Amino acid substitutions at the other proline
residue within the (Pxx)4 domain (i.e., P82A) and the pro-tides 112–2984 was used to probe the Southern blot. To
evaluate the relative amounts of template DNA in the cell line residues within the single PxxP motif at the C-termi-
lysates, 2.5 ml was used in PCR with primer pairs specific
for HLA-DQ (Lee et al., 1991). The amplified products
were analyzed by electrophoresis in 1.2% agarose gels
and visualized by ethidium bromide staining.
RESULTS
Sequence requirements for Nef-associated serine
kinase activity
To determine if, in addition to the membrane targeting
signal and the conserved arg–arg residues at positions
109 and 110, other amino acids within the coding region of
Nef are necessary for association with the cellular serine
kinase activity, site-directed mutagenesis was performed
to individually replace the serine, threonine, and proline
residues of HIV-1SF2 Nef with alanine. Charge cluster-to-
alanine mutagenesis (Bass et al., 1991; Cunningham and
Wells, 1989) was also employed to replace groups of
charge residues within the primary sequence. As controls,
the glycine at position 2 was mutated to remove the mem- FIG. 1. Kinase association with transiently expressed mutant Nef.
293 cells were transfected with wild-type or mutant pRcCMV-Nef orbrane targeting signal, and the arg–arg at positions 109
mock transfected. Nef protein expressed after 72 hr was immunoprecip-and 110 were mutated to leucine to generate the G2A and
itated with Nef-specific polyclonal antibody or with prebleed serumRR mutants, respectively. In addition to abrogating the
and analyzed for association with cellular kinase (A). Alternatively, 293
ability of Nef to associate with the serine kinase activity transfected cells were radiolabeled and immunoprecipitated with Nef-
(Sawai et al., 1995), the G2A mutation has been shown to specific antibody to determine relative level of Nef expression (B). Mo-
lecular size standards are shown at the right.affect the ability of Nef to down-regulate CD4 and to pro-
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nus (i.e., P151A and P154A) did not have any apparent
effect. The loss in the ability of the P73A, P76A, and
P79A mutant proteins to associate with the kinase activity
cannot be explained by differences in their expression
in transfected cells. Although different levels of the wild-
type and mutant proteins were expressed as determined
by radioimmunoprecipitation with a polyclonal anti-Nef
antisera, there was no correlation between the level of
protein expression and ability of the protein to associate
with the serine kinase activity (Figs. 1A and B). For exam-
ple, the level of expression of P73A is comparable to that
of P82A, whereas those of P76A and P79A are similar to
P151A and P151A/P154A. However, only the P82A,
P151A, and P151A/P154A mutant Nef proteins associate
with the serine kinase activity. Of the charge cluster mu-
tants examined, only amino acid substitutions at R109R110
(the RR control mutant) of Nef abolished kinase associa-
tion without an apparent effect on the expression and
stability of the mutant protein (Fig. 1A). Control mutant
R110L with a single amino acid substitution at position
110, gave similar results (Fig. 1A). These observations
made with native RR and R110L proteins are in agree-
ment with our previous published data using CD8/Nef
fusion proteins (Sawai et al., 1995).
Serine kinase association is not required for CD4
down-regulation by Nef
To determine the effect of the serine kinase/Nef asso-
ciation on Nef-mediated cell-surface CD4 down-modula-
tion, transient transfections in 293 cells were performed
with CD8/Nef expression constructs carrying representa-
tive Nef mutants and a CD4 expression plasmid (pCD4;
Lenburg and Landau, 1993). CD8 fusion protein express-
ing Nef in the antisense orientation and a native Nef
protein defective in myristoylation and hence in the ability
to down-regulate CD4 cell surface expression were used
as controls. As noted above, we have previously shown
that the CD8–wild-type Nef fusion protein associates
with the serine kinase activity, whereas the mutant CD8–
RR Nef protein does not (Sawai et al., 1995). CD4 display
on the cell surface of transfected CD8-positive cells (i.e.,
Nef expressing cells) was analyzed by flow cytometry at
40 hr posttransfection. CD4 downregulation was deter-
mined by comparing the percentage of CD4/CD8-positive
FIG. 2. Cell surface CD4 down-modulation by Nef mutant proteins. 3mgcells in cultures transfected with CD8/Nef expression
of wild-type or mutant CD8/Nef expression plasmid, together with expres-plasmids to cultures transfected with the CD8/antisense
sion plasmids for CD4 and b-gal (1 mg each) were transfected into 293Nef plasmid. Results are summarized in Fig. 2.
cells, and cell surface CD4 expression on CD8-positive-transfected cells
We observe that the control myristoylation-defective (i.e., Nef-expressing cells) was determined at 40 hr posttransfection by flow
mutant protein G2A and the chimeric CD8/antisense Nef cytometry as described under Materials and Methods. Controls included
transfection with a native myristoylation-negative mutant Nef expressionprotein are unable to down-regulate cell-surface CD4
plasmid (G2A Nef) and a chimeric CD8/antisense Nef expression plasmid(Figs. 2B–2D). In contrast, the hybrid CD8/wild-type Nef
(CD8/antisense Nef). Data represent one of two independent experiments.protein downregulates the CD4 surface expression by
(A) pCH110 alone and (B) pCH110 with pCD4. In the subsequent panels,
approximately 60% (compare values in upper right quad- pCH110 and pCD4 were cotransfected with (C) G2A Nef; (D) CD8/antisense
rants of Figs. 2D and 2E). The P73A, P76A, P79A, and Nef; (E) CD8/wild-type Nef; (F) CD8/P73A Nef; (G) CD8/P76A Nef; (H) CD8/
P79A Nef; (I) CD8/P82A Nef; and (J) CD8/RR Nef.P82A Nef mutant proteins maintain the ability to down-
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of Nef to enhance virion infectivity. The P82A mutant
virus, whose Nef protein associates with the serine ki-
nase activity, displays enhanced infectivity characteris-
tics similar to that of wild-type virus. This correlation is
observed both in the MAGI system and in infection of
resting or stimulated PBMCs. In the MAGI system, the
P73A, P76A, P79A, and RR mutant viruses are three to five
times less infectious than the wild-type virus, whereas
infectivity of the P82A mutant virus is slightly less than
that of wild-type. In infection of resting or stimulated
PBMCs, the kinetics of replication of the P82A virus is
consistently more similar to that of wild-type, whereas
replication of the kinase-association-negative mutant vi-
ruses (P73A, P76A, P79A, and RR) display an intermedi-
FIG. 3. Infectivity of Nef-mutant virions. MAGI cells were infected
with equivalent amounts of virus produced by transfection of 293 cells
and standardized for p24 content by ELISA. The number of blue foci
were scored after staining with X-gal 40 hr postinfection. Values shown
are the average of duplicate infections and are representative of two
independent experiments.
modulate the CD4 receptor molecule to levels compara-
ble to that of the wild-type (Figs. 2F–2I), but substitutions
at R109R110 (RR) diminish substantially the ability of the
mutant protein to down-regulate CD4 cell surface expres-
sion (Fig. 2J). The results with the P73A, P76A, and P79A
mutants (Figs. 2F, 2G, 2H, respectively) show that serine
kinase association with Nef is not required for down-
regulation of the CD4 receptor since these mutants are
defective in kinase association (Fig. 1).
Correlation between serine kinase association and
enhanced virion infectivity
To determine whether serine kinase association with
Nef is required for Nef-mediated enhancement of viral
replication, selected Nef mutant sequences were intro-
duced into full-length infectious HIV-1SF2 DNA and mutant
viruses were generated by transfection into 293 cells.
The infectivity of the mutant viruses was compared to
that of wild-type virus using both the MAGI system and
infection of resting or stimulated peripheral blood mono-
nuclear cells (PBMC). The MAGI system utilizes CD4-
positive HeLa cells which contain the b-galactosidase
FIG. 4. Infection of resting and stimulated PBMC by Nef mutant
(b-gal) gene under the control of the HIV-1 LTR (Kimpton proviruses. Infection of resting (A) or PHA-stimulated (B) PBMC was
and Emerman, 1992). Production of the viral Tat protein performed in duplicate and p24 production in supernatants of infected
cultures was monitored as described. Data presented in (A) were ob-as a result of HIV infection promotes the expression of
tained using 3.0 ng p24 equivalent of the viruses and in (B) using 0.5b-gal which can be scored in situ by visual detection
ng p24 equivalent. Similar results were obtained from two infectionsof blue color derived from conversion of X-gal. The nef
performed in PMBC derived from two independent donors. Data pre-
deletion mutant virus (Xho0) served as control in these sented are averages of the duplicate p24 values obtained from one of
studies. Results are presented in Figs. 3 and 4 and show these infections. (s) wild-type; (l) Xho(0); (n) P73A; (,) P76A; (L)
P79A; (h) P82A; (j) RR.a correlation between kinase association and the ability
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ate pattern between that of wild-type and the Nef-defec- of their Nef proteins to associate with the serine kinase
activity. As shown, the highest level of proviral DNA synthe-tive Xho(0) viruses.
sis was obtained in cells infected with wild-type virus fol-
Serine kinase association with Nef is necessary for lowed by those infected with the P82A mutant provirus (Fig.
efficient proviral DNA synthesis 5A). The signal present at time zero for the wild-type sample
most likely represents viral DNA synthesis in these cellsSince the mechanism by which Nef enhances virion in-
during the 1-hr incubation period with the virus. The Xho(0)fectivity appears to be mediated through stimulation of pro-
Nef-deletion mutant virus exhibited significant deficiency inviral DNA synthesis (Aiken and Trono, 1995; Chowers et
its ability to produce viral DNA, whereas the RR and theal., 1995; Schwartz et al., 1995), we examined proviral DNA
other proline mutant viruses (P73A, P76A, and P79A) exhib-synthesis in MAGI cells infected with viruses whose Nef
ited intermediate levels. These differences in viral DNAproteins are shown in Fig. 1 to be defective in their ability
synthesis cannot be explained by differences in templateto associate with the serine kinase activity. Proviral DNA
DNA since at any given time point postinfection, the amplifi-synthesis was analyzed by PCR with primers specific for
cation signal for HLA-DQ is comparable among the variousthe early, minus-strand strong stop DNA and for late reverse
samples (Fig. 5B). Both HIV-1 primer pairs used in thesetranscribed DNA. Amplification with primers specific for
analyses yielded similar results and the patterns of viralHLA-DQ was performed to control for amount of input tem-
DNA synthesis for the various viruses are consistent withplate DNA. Results are shown in Fig. 5 and show that at
their level of infectivity in the MAGI cells (Fig. 3). Theseany given time point postinfection, lower levels of proviral
results indicate that the serine kinase association with NefDNA synthesis are observed in cells infected with viruses
is necessary for efficient reverse transcription.that are defective both in virion infectivity and in the ability
DISCUSSION
We have previously identified two domains of Nef that
are required for association with the cellular serine ki-
nase activity: the membrane-targeting signal at the N-
terminus (G2A mutation) and the conserved arg–arg resi-
dues within the central region (RR mutation) (Sawai et
al., 1995). In the present study, an additional domain of
Nef, the (Pxx)4 region, is also shown to be important for
Nef association with the cellular serine kinase activity.
The (Pxx)4 and arg–arg residues are located, respec-
tively, within the Block A and B ‘‘Nef-defining’’ sequences
described by Shugars et al. (1993). We find that the muta-
tions of the arg–arg residues exert functional effects
similar to those reported for the G2A mutation (Aiken et
al., 1994; Chowers et al., 1994). The RR mutant protein
is unable to down-modulate the CD4 receptor molecule
in transient expression systems (Fig. 2), and the mutant
virus is impaired in infectivity (Figs. 3 and 4) and in the
establishment of efficient proviral DNA synthesis (Fig. 5).
In contrast, mutations in the proline-rich region affect
only the efficiency of proviral DNA synthesis and viral
FIG. 5. Proviral DNA synthesis in Nef-infected cells. MAGI cells were
infectivity. The observation that the proline mutants caninfected with wild-type and mutant Nef viruses as described under
still down-regulate the CD4 receptor molecule indicatesMaterials and Methods. At 0 hr postinfection (equivalent to the time
after 1 hr of incubation of virus with cells), and at 4, 8, and 24 hr that their inability to mediate efficient proviral DNA syn-
postinfection, 4 1 105 cells were harvested and cell lysates prepared. thesis and virion infectivity is not the result of possible
(A) PCR amplification with primers that detect both early and late prod- global protein structural changes introduced by the muta-
ucts of HIV-1 reverse transcription. Products amplified were detected
tions. With respect to the RR mutations, the multiple func-by Southern blotting with a 2.8-kb EcoRV fragment of HIV-1SF2 encom-
tional defects displayed is not merely the result of proteinpassing nucleotides 112–2984. Lane 1, wild-type; lane 2, Xho(0); lane
3, P73A; lane 4, P76A; lane 5, P79A; lane 6, P82A; lane 7, RR; and lane instability (Fig. 1) and also does not appear to be due to
8, uninfected control. (B) Amplification of HLA-DQ sequences. t:0, t:4, a perturbation of the global protein conformation as a
t:8, and t:24 indicate 0, 4, 8, and 24 hr postinfection, respectively. For consequence of the mutations introduced for the follow-
standardization, 0.25X, 1X, and 4X amounts of cellular DNA (with 1X
ing reasons. Charged residues are likely to occupy ex-representing 2.5 ml of cell lysate) prepared from uninfected control cells
posed positions in tertiary structure and these substitu-collected at 4 hr postinfection were amplified with HLA-DQ-specific
primers. tions are not likely to disrupt the overall conformation
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TABLE 2
Summary of Results
Serine kinase CD4 down Enhancement virion Efficient proviral DNA
Nef mutant association modulation infectivity synthesis
Myristoylation 0 0 0 ND
arg-arg 0 0 0 0
(Pxx)4 0 / 0 0
Note. ND, not done.
and inherent stability of the molecule (Bass et al., 1991; showing the importance of the proline-rich (Pxx)4 domain
of Nef, which is reminiscent of an SH-3 binding domain,Cunningham and Wells, 1989). In addition, we observe
that (i) a single amino acid substitution at position 110 in mediating kinase binding and enhanced HIV infectivity,
there are important differences. In our study, we detect(R110L) gives similar results to the RR mutant (Fig. 1),
and (ii) other charge substitution mutants in the same the binding of a serine kinase (Sawai et al., 1994), and
not a subset of Src-related tyrosine kinases as reportedregion (e.g., E112A/D115A; Table 1) as well as multiple
mutations generated in other regions of the protein did by Saksela et al. (1995). This serine kinase is present in
lymphoid and nonlymphoid cells, whereas the src-relatednot abolish kinase association. Nevertheless, a detailed
comparison of the structures of wild-type and RR mutant kinase Hck described by Saksela et al. is not expressed
in lymphoid cells. Furthermore, our results indicate thatproteins is needed to exclude the possibility of a global
conformational change in the mutant protein. Taken to- the conservation of an intact PxxP motif does not confer
on Nef the ability to associate with the serine kinasegether, our genetic and biochemical analyses of Nef
identify three functional domains of Nef that participate activity or to enhance proviral DNA synthesis and virion
infectivity. The single proline mutant Nef proteins (e.g.,in cellular interaction events leading to the observed
phosphorylation of the p62 and p72-kDa proteins in the P73A, P76A, P79A) all contain some intact PxxP motifs
and yet are unable to associate with the serine kinasein vitro kinase assay of Nef immunoprecipitates. Our
functional studies of various Nef mutant proteins and activity. Of note is the presence of the two middle pro-
lines in the (Pxx)4 repeat of the P73A mutant protein.viruses establish a link between serine kinase/Nef asso-
ciation and the ability of Nef to promote efficient reverse These two prolines have been suggested to constitute
the PxxP defining residues (Lee et al., 1995), yet thetranscription and virion infectivity (Table 2).
The observations that membrane targeting of Nef is mutant P73A protein is unable to associate with the ser-
ine kinase activity and to promote efficient proviral DNAimportant for its function and that Nef interacts with a
cellular kinase are consistent with previous cell culture synthesis and virion infectivity. Last, in contrast to the
observation that the Nef/Src kinases Hck and Lyn associ-and in vivo studies, indicating that this viral protein alters
a cell signalling pathway (Baur et al., 1994; De and ation is detected only in cotransfected cells (Saksela et
al., 1995), the serine kinase association describe here isMarsh, 1994; Du et al., 1995, 1996; Greenway et al., 1994,
1995; Skowronski et al., 1993). Our finding that mutations found with both HIV and SIV Nefs present in transfected
and acutely or chronically infected cells (Sawai et al.,in the core domain, specifically the conserved arg–arg
residues, affect multiple Nef functions, whereas muta- 1994, 1995).
Protein kinases mediate signal transduction and con-tions in the proline-rich region alter only the enhanced
infectivity function of Nef suggests that in this signalling trol many aspects of cellular physiology (Hunter, 1995;
Johnson and Vallincourt, 1994). The observation that Nefpathway, the cellular interaction event that occurs via
the arg–arg residues lies upstream of another putative interacts with a serine kinase provides a mechanism by
which such an interaction might lead to efficient proviralinteraction event via the proline-rich region. Furthermore,
since the enhanced infectivity function of Nef is linked DNA synthesis in infected cells. Nef has recently been
reported to be present in purified virion particles (Pandorito the serine kinase association, our data suggest that
the proline-rich domain of Nef is the serine kinase bind- et al., 1996; Welker et al., 1996). The interaction of virion-
associated Nef with its cellular target in the infected cellsing site. It is conceivable that the interacting event via
the arg–arg residues in the central domain of Nef results may lead to cell activation and provide an intracellular
environment that is favorable for proviral DNA synthesis.in posttranslational modification of the protein (e.g., phos-
phorylation, GTP-binding) that regulates its ability to exert Alternatively, activation of a signalling pathway in the
producer cell by Nef might result in modification of an-the multiple functions reported for Nef.
Although our findings are in agreement with those re- other virion-associated viral or cellular gene product that
facilitates early steps of the viral cell cycle. Indeed, aported by others (Lee et al., 1995; Saksela et al., 1995)
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mapping of hGH-receptor interactions by alanine-scanning mutagen-serine/threonine kinase that phosphorylates the matrix
esis. Science 244, 1081–1085.protein and facilitates translocation of the preintegration
de Rhonde, A., Klaver, B., Keulen, W., Smit, L., and Goudsmit, J. (1992).complex to the nucleus has been reported to be pack- Natural HIV-1 Nef accelerates virus replication in primary human
aged within purified virions (Bukrinskaya et al., 1996). It lymphocytes. Virology 188, 391–395.
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participate in this activation pathway by Nef, will lead to in macaque monkeys. Cell 82, 665–674.
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by unusual strains of simian immunodeficiency virus. J. Virol. 70,novel therapeutic targets for the control of progression
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